- Home
- ACRV vs PMEC Comparison
ACRV vs PMEC Comparison
Compare ACRV & PMEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACRV
- PMEC
- Stock Information
- Founded
- ACRV 2018
- PMEC 1984
- Country
- ACRV United States
- PMEC Singapore
- Employees
- ACRV N/A
- PMEC N/A
- Industry
- ACRV Medicinal Chemicals and Botanical Products
- PMEC
- Sector
- ACRV Health Care
- PMEC
- Exchange
- ACRV Nasdaq
- PMEC Nasdaq
- Market Cap
- ACRV 40.4M
- PMEC 46.1M
- IPO Year
- ACRV 2022
- PMEC 2023
- Fundamental
- Price
- ACRV $1.34
- PMEC $1.54
- Analyst Decision
- ACRV Buy
- PMEC
- Analyst Count
- ACRV 7
- PMEC 0
- Target Price
- ACRV $17.60
- PMEC N/A
- AVG Volume (30 Days)
- ACRV 379.9K
- PMEC 63.4K
- Earning Date
- ACRV 08-12-2025
- PMEC 01-01-0001
- Dividend Yield
- ACRV N/A
- PMEC N/A
- EPS Growth
- ACRV N/A
- PMEC N/A
- EPS
- ACRV N/A
- PMEC N/A
- Revenue
- ACRV N/A
- PMEC $74,310,000.00
- Revenue This Year
- ACRV N/A
- PMEC N/A
- Revenue Next Year
- ACRV N/A
- PMEC N/A
- P/E Ratio
- ACRV N/A
- PMEC N/A
- Revenue Growth
- ACRV N/A
- PMEC 3.94
- 52 Week Low
- ACRV $1.05
- PMEC $0.49
- 52 Week High
- ACRV $10.16
- PMEC $1.56
- Technical
- Relative Strength Index (RSI)
- ACRV 55.88
- PMEC 66.59
- Support Level
- ACRV $1.15
- PMEC $1.37
- Resistance Level
- ACRV $1.38
- PMEC $1.46
- Average True Range (ATR)
- ACRV 0.09
- PMEC 0.12
- MACD
- ACRV 0.02
- PMEC 0.02
- Stochastic Oscillator
- ACRV 83.33
- PMEC 92.68
About ACRV Acrivon Therapeutics Inc.
Acrivon Therapeutics Inc is a clinical-stage biopharmaceutical company developing oncology medicines that the Firm matches to patients whose tumors are predicted to be sensitive to each specific medicine by utilizing its proteomics-based patient responder identification platform. The company's pipeline includes the Phase 2 lead program, ACR-368, referred to as prexasertib, a targeted oncology asset, as well as preclinical stage pipeline programs targeting critical nodes in the DNA Damage Response and cell cycle regulation pathways, including WEE1, a protein kinase, and PKMYT1, a closely related protein serine/threonine kinase.
About PMEC Primech Holdings Ltd.
Primech Holdings Ltd is a technology-driven facilities services provider in the public and private sectors operating mainly in Singapore. The services offered by the company include Facilities services, Stewarding services, Cleaning services to offices, Cleaning services to homes, and Cleaning Supplies.